news_image.jpg

New hormone breast cancer treatment reduces risk of recurrence by 25%

21 Sep 2020



According to research presented at the European Society for Medical Oncology's virtual conference (ESMO), a new hormonal breast cancer treatment which includes the substance abemaciclib may reduce recurrence by up to 25%.

News Medical



Issue 49 - Autumn 2020 - Supporting your Career

Latest Newsletter

Issue 49 - Autumn 2020 - Supporting your Career

Issue 49 - Autumn 2020 - Supporting your Career

Newsletter Archive

Previous newsletters can be viewed and downloaded from the archive.

Newsletter Archive